Total Funding
31
52
Total FundingSeries A raised
Growth Score 31 in past quarter
-12 pts
Heat Score 52 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
59563
uMed enables healthcare providers to run patient research more efficiently through automating the clinical studies process
- Matt Wilson: CEO & FounderPast Role: Ampersand & Ampersand, Chief Medical Officer
About the Company
uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access to
regulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams